Terms: = Leukemia AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1
12 results:
1. H1Innovative approaches to combat anti-cancer drug resistance: Targeting lncRNA and autophagy.
Zhong C; Xie Z; Duan S
Clin Transl Med; 2023 Oct; 13(10):e1445. PubMed ID: 37837401
[TBL] [Abstract] [Full Text] [Related]
2. Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets.
Alahdal M; Elkord E
Clin Transl Med; 2023 Sep; 13(9):e1425. PubMed ID: 37735815
[TBL] [Abstract] [Full Text] [Related]
3. Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH.
Liu X; Tan Q; Wen J; Wang X; Yang G; Li Y; Lu M; Ye W; Si A; Ma S; Ding T; Sun L; Liu F; Zhang M; Jiang T; Gao W
J Transl Med; 2023 Aug; 21(1):572. PubMed ID: 37626430
[TBL] [Abstract] [Full Text] [Related]
4. Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid leukemia.
Konopleva M; Thirman MJ; Pratz KW; Garcia JS; Recher C; Pullarkat V; Kantarjian HM; DiNardo CD; Dail M; Duan Y; Chyla B; Potluri J; Miller CL; Wei AH
Clin Cancer Res; 2022 Jul; 28(13):2744-2752. PubMed ID: 35063965
[TBL] [Abstract] [Full Text] [Related]
5. Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid leukemia and IDH1/2 Mutations.
Pollyea DA; DiNardo CD; Arellano ML; Pigneux A; Fiedler W; Konopleva M; Rizzieri DA; Smith BD; Shinagawa A; Lemoli RM; Dail M; Duan Y; Chyla B; Potluri J; Miller CL; Kantarjian HM
Clin Cancer Res; 2022 Jul; 28(13):2753-2761. PubMed ID: 35046058
[TBL] [Abstract] [Full Text] [Related]
6. Assessment of molecular response to tyrosine kinase inhibitors in Tunisian Patients with Chronic Myeloid leukemia.
Frikha R; Kassar O; Elloumi M; Kamoun H
J Oncol Pharm Pract; 2022 Dec; 28(8):1826-1831. PubMed ID: 34846219
[TBL] [Abstract] [Full Text] [Related]
7. Targeting acute myeloid leukemia cells by CD33 receptor-specific MoS
Štefík P; Annušová A; Lakatoš B; Elefantová K; Čepcová L; Hofbauerová M; Kálosi A; Jergel M; Majková E; Šiffalovič P
Biomed Mater; 2021 Aug; 16(5):. PubMed ID: 34280914
[TBL] [Abstract] [Full Text] [Related]
8. Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia.
Cui XY; Tjønnfjord GE; Kanse SM; Dahm AEA; Iversen N; Myklebust CF; Sun L; Jiang ZX; Ueland T; Campbell JJ; Ho M; Sandset PM
Sci Rep; 2021 Mar; 11(1):5127. PubMed ID: 33664415
[TBL] [Abstract] [Full Text] [Related]
9. Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update.
Fleming BD; Ho M
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32575752
[TBL] [Abstract] [Full Text] [Related]
10. Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.
Khoury HJ; Loberiza FR; Ringdén O; Barrett AJ; Bolwell BJ; Cahn JY; Champlin RE; Gale RP; Hale GA; Urbano-Ispizua A; Martino R; McCarthy PL; Tiberghien P; Verdonck LF; Horowitz MM
Blood; 2006 Feb; 107(4):1712-6. PubMed ID: 16239431
[TBL] [Abstract] [Full Text] [Related]
11. Many accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery.
Grate LR
BMC Bioinformatics; 2005 Apr; 6():97. PubMed ID: 15826317
[TBL] [Abstract] [Full Text] [Related]
12. Cancer mortality among workers in the German rubber industry: 1981-91.
Weiland SK; Mundt KA; Keil U; Kraemer B; Birk T; Person M; Bucher AM; Straif K; Schumann J; Chambless L
Occup Environ Med; 1996 May; 53(5):289-98. PubMed ID: 8673175
[TBL] [Abstract] [Full Text] [Related]
